II. Development and future prospects of the third-generation EGFR-tyrosine kinase inhibitor

Shinya Sakata, Eiji Iwama, Isamu Okamoto

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)935-939
Number of pages5
JournalJapanese Journal of Cancer and Chemotherapy
Issue number8
Publication statusPublished - Aug 2015

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this